Natural Beauty Bio-Technology Limited (0157.HK)
HKD 0.48
(-2.06%)
HKD 0.48
(-2.06%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 308.05 Million HKD | 7.69% |
| 2022 | 286.07 Million HKD | 2.44% |
| 2021 | 279.24 Million HKD | 21.65% |
| 2020 | 229.53 Million HKD | 14.57% |
| 2019 | 200.34 Million HKD | 57.61% |
| 2018 | 127.11 Million HKD | -0.02% |
| 2017 | 127.13 Million HKD | -24.1% |
| 2016 | 167.51 Million HKD | 7.4% |
| 2015 | 155.96 Million HKD | -23.48% |
| 2014 | 203.82 Million HKD | 5.17% |
| 2013 | 193.8 Million HKD | 42.44% |
| 2012 | 136.06 Million HKD | -20.17% |
| 2011 | 170.44 Million HKD | 7.67% |
| 2010 | 158.29 Million HKD | 21.31% |
| 2009 | 130.49 Million HKD | -23.16% |
| 2008 | 169.81 Million HKD | 45.56% |
| 2007 | 116.66 Million HKD | -1.54% |
| 2006 | 118.48 Million HKD | 1.12% |
| 2005 | 117.17 Million HKD | 22.57% |
| 2004 | 95.6 Million HKD | 18.28% |
| 2003 | 80.82 Million HKD | -24.48% |
| 2002 | 107.03 Million HKD | -35.08% |
| 2001 | 164.87 Million HKD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 296.21 Million HKD | 0.0% |
| 2023 Q2 | 286.6 Million HKD | 0.0% |
| 2023 FY | 308.05 Million HKD | 7.69% |
| 2023 Q4 | 308.05 Million HKD | 0.0% |
| 2022 Q2 | 279.52 Million HKD | 0.0% |
| 2022 Q4 | 286.07 Million HKD | 0.0% |
| 2022 FY | 286.07 Million HKD | 2.44% |
| 2021 Q2 | 255.32 Million HKD | 0.0% |
| 2021 FY | 279.24 Million HKD | 21.65% |
| 2021 Q4 | 279.24 Million HKD | 0.0% |
| 2020 FY | 229.53 Million HKD | 14.57% |
| 2020 Q2 | 203.64 Million HKD | 0.0% |
| 2020 Q4 | 229.53 Million HKD | 0.0% |
| 2019 Q4 | 200.34 Million HKD | 0.0% |
| 2019 FY | 200.34 Million HKD | 57.61% |
| 2019 Q2 | 154.3 Million HKD | 0.0% |
| 2018 Q2 | 183.84 Million HKD | 0.0% |
| 2018 FY | 127.11 Million HKD | -0.02% |
| 2018 Q4 | 127.11 Million HKD | 0.0% |
| 2017 Q4 | 127.13 Million HKD | 0.0% |
| 2017 FY | 127.13 Million HKD | -24.1% |
| 2017 Q2 | 231.76 Million HKD | 0.0% |
| 2016 FY | 167.51 Million HKD | 7.4% |
| 2016 Q2 | 204.5 Million HKD | 0.0% |
| 2016 Q4 | 167.51 Million HKD | 0.0% |
| 2015 Q4 | 155.96 Million HKD | 0.0% |
| 2015 FY | 155.96 Million HKD | -23.48% |
| 2015 Q2 | 258.78 Million HKD | 0.0% |
| 2014 Q4 | 203.82 Million HKD | 0.0% |
| 2014 FY | 203.82 Million HKD | 5.17% |
| 2014 Q2 | 247.96 Million HKD | 0.0% |
| 2013 FY | 193.8 Million HKD | 42.44% |
| 2013 Q4 | 193.8 Million HKD | 0.0% |
| 2013 Q2 | 129.75 Million HKD | 0.0% |
| 2012 FY | 136.06 Million HKD | -20.17% |
| 2012 Q2 | 145.93 Million HKD | 0.0% |
| 2012 Q4 | 136.06 Million HKD | 0.0% |
| 2011 Q2 | 166.46 Million HKD | 0.0% |
| 2011 Q4 | 170.44 Million HKD | 0.0% |
| 2011 FY | 170.44 Million HKD | 7.67% |
| 2010 Q2 | 112.94 Million HKD | 0.0% |
| 2010 FY | 158.29 Million HKD | 21.31% |
| 2010 Q4 | 158.29 Million HKD | 0.0% |
| 2009 Q4 | 130.49 Million HKD | 0.0% |
| 2009 FY | 130.49 Million HKD | -23.16% |
| 2008 FY | 169.81 Million HKD | 45.56% |
| 2007 FY | 116.66 Million HKD | -1.54% |
| 2006 FY | 118.48 Million HKD | 1.12% |
| 2005 FY | 117.17 Million HKD | 22.57% |
| 2004 FY | 95.6 Million HKD | 18.28% |
| 2003 FY | 80.82 Million HKD | -24.48% |
| 2002 FY | 107.03 Million HKD | -35.08% |
| 2001 FY | 164.87 Million HKD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Innovative Pharmaceutical Biotech Limited | 1.06 Billion HKD | 71.036% |
| China Overseas Nuoxin International Holdings Limited | 109.1 Million HKD | -182.361% |
| Prosperous Future Holdings Limited | 177.1 Million HKD | -73.938% |
| Huasheng International Holding Limited | 675.58 Million HKD | 54.401% |
| Fourace Industries Group Holdings Limited | 61.8 Million HKD | -398.437% |
| Evergreen Products Group Limited | 786.46 Million HKD | 60.83% |
| EC Healthcare | 2.97 Billion HKD | 89.629% |
| Ming Fai International Holdings Limited | 772.01 Million HKD | 60.097% |
| Blue Moon Group Holdings Limited | 1.61 Billion HKD | 80.959% |
| SuperRobotics Holdings Limited | 172.27 Million HKD | -78.821% |
| Takbo Group Holdings Limited | 42.84 Million HKD | -618.941% |
| Hyfusin Group Holdings Limited | 181.34 Million HKD | -69.872% |